28.04.2010 • News

Dow Chemical Profit, Revenue Spike

Dow Chemical posted a better-than-expected first-quarter profit on Wednesday as pricing, volume and sales spiked.

Net income rose to $466 million, or 41 cents per share, from $24 million, or 3 cents per share, a year earlier.

Excluding costs related to the 2009 acquisition of rival Rohm & Haas and restructuring, Dow earned 43 cents per share. By that measure, analysts expected earnings of 30 cents, according to Thomson Reuters I/B/E/S. Revenue rose 48.4% to $13.42 billion. Analysts expected $12.93 billion. Midland, Mich.-based Dow bought rival Rohm & Haas last April in a deal that sharply leveraged its balance sheet. Since then, the company has been selling off assets to repay the loan.

Dow peer DuPont said on Tuesday that first-quarter profit more than doubled.

Company

The Dow Chemical Company

100 Larkin Center
48674 Midland

Company contact







Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

most read